Pitt Faculty and Serial Entrepreneur Leverages NSF I-Corps to Launch New Venture Paul Ohodnicki was no stranger to innovation commercialization when he arrived at the University of Pittsburgh in 2020.
Each year the biotech industry gathers to discuss trends, share insights, and explore partnership opportunities at the BIO International Convention, the world’s largest meeting of its kind. The University of Pittsburgh Office of Innovation and Entrepreneurship (OIE) was well represented at this gathering of more than 6,000 industry leaders from startups to biotech giants, academia, non-profits and government entities from around the world, held earlier in June in San Diego.
We welcome our partner in the Pitt innovation and entrepreneurship ecosystem, the Clinical and Translational Sciences Institute (CTSI), for a guest post on an exciting funding opportunity to bring evidence developed in Pitt labs into a clinical setting.
Neoolife Is Pioneering Tissue Engineering Across Two Continents Revolutionizing Heart Valve Replacement with Double Component Deposition (DCD) Antonio D’Amore arrived at the University of Pittsburgh in 2008 to pursue his doctoral studies in the Department of Bioengineering with an appointment to the prestigious McGowan Institute for Regenerative Medicine.
Pitt’s Office of Industry and Economic Partnerships (OIEP) will be attending the BIO International Convention in San Diego from June 3-6, 2024. “BIO” is the largest and most comprehensive event for biotechnology business development and partnering, representing the full ecosystem of biotech with over 20,000 industry leaders attending from across the globe.